474
Views
73
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: A randomized, controlled pilot trial with long-term follow-up

, PhD , MD, , , , , , , , , & show all
Pages 1334-1342 | Received 28 Dec 2004, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Shubhra Mishra, Daya Krishna Jha, Anupam Kumar Singh, Praveen Kumar-M, Amol Patil & Vishal Sharma. (2021) Antibiotics for induction and maintenance of remission in ulcerative colitis: systematic review and meta-analysis. Expert Review of Gastroenterology & Hepatology 15:10, pages 1215-1223.
Read now
Wenjie Xi, Zongwei Li, Rongrong Ren, Xiao-Yong Sai, Lihua Peng & Yunsheng Yang. (2021) Effect of antibiotic therapy in patients with ulcerative colitis: a meta-analysis of randomized controlled trials. Scandinavian Journal of Gastroenterology 56:2, pages 162-170.
Read now
Katsuyoshi Matsuoka. (2021) Fecal microbiota transplantation for ulcerative colitis. Immunological Medicine 44:1, pages 30-34.
Read now
Laura Noddin Rosenberg & Mark A Peppercorn. (2010) Efficacy and safety of drugs for ulcerative colitis. Expert Opinion on Drug Safety 9:4, pages 573-592.
Read now
Sandra Macfarlane, Helen Steed & George T. Macfarlane. (2009) Intestinal bacteria and inflammatory bowel disease. Critical Reviews in Clinical Laboratory Sciences 46:1, pages 25-54.
Read now
Jun Nishikawa, Takahiko Kudo, Shinji Sakata, Yoshimi Benno & Toshiro Sugiyama. (2009) Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis. Scandinavian Journal of Gastroenterology 44:2, pages 180-186.
Read now
Akira Harada, Toshifumi Ohkusa, Kaoru Kushima, Mitsuo Sakamoto, Yoshimi Benno, Kazuko Beppu, Tomoyoshi Shibuya, Naoto Sakamoto & Sumio Watanabe. (2008) Identification of bacteria from blood in febrile patients with ulcerative colitis by terminal restriction fragment length polymorphism profile analysis of 16S rRNA gene. Scandinavian Journal of Gastroenterology 43:4, pages 423-430.
Read now

Articles from other publishers (66)

Daya K. Jha, Shubhra Mishra, Usha Dutta & Vishal Sharma. (2024) Antibiotics for inflammatory bowel disease: Current status. Indian Journal of Gastroenterology 43:1, pages 145-159.
Crossref
Stephan C. Bischoff, Palle Bager, Johanna Escher, Alastair Forbes, Xavier Hébuterne, Christian Lodberg Hvas, Francisca Joly, Stansilaw Klek, Zeljko Krznaric, Johann Ockenga, Stéphane Schneider, Raanan Shamir, Kalina Stardelova, Darija Vranesic Bender, Nicolette Wierdsma & Arved Weimann. (2023) ESPEN guideline on Clinical Nutrition in inflammatory bowel disease. Clinical Nutrition 42:3, pages 352-379.
Crossref
Toshifumi Ohkusa, Yuriko Nishikawa & Nobuhiro Sato. (2023) Gastrointestinal disorders and intestinal bacteria: Advances in research and applications in therapy. Frontiers in Medicine 9.
Crossref
Yao-Wen Cheng & Monika Fischer. (2023) Fecal Microbiota Transplantation. Clinics in Colon and Rectal Surgery.
Crossref
Shigeo Koido, Sankichi Horiuchi, Shin Kan, Tsuuse Bito, Zensho Ito, Kan Uchiyama, Masayuki Saruta, Nobuhiro Sato & Toshifumi Ohkusa. (2022) The stimulatory effect of fusobacteria on dendritic cells under aerobic or anaerobic conditions. Scientific Reports 12:1.
Crossref
Morris Gordon, Vassiliki Sinopoulou, Ciaran Grafton-Clarke & Anthony K Akobeng. (2022) Antibiotics for the induction and maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2022:5.
Crossref
Monika Fischer & Alexander Khoruts. (2022) Oral lyophilised microbiota for the treatment of ulcerative colitis. The Lancet Gastroenterology & Hepatology 7:2, pages 108-109.
Crossref
Craig Haifer, Sudarshan Paramsothy, Nadeem O Kaakoush, Aiasha Saikal, Simon Ghaly, Tao Yang, Laurence Don Wai Luu, Thomas J Borody & Rupert W Leong. (2022) Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. The Lancet Gastroenterology & Hepatology 7:2, pages 141-151.
Crossref
Sanjiv Singh, Punita Aggarwal, Satyam Sharma & V. Ravichandiran. 2022. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 241 253 .
Xing-qi Wang, Hao Chen, Yu-zhi Gao, Yan-xiu Huang, Rui-juan Zhang, Jun Xie, Yu Li, Yu-qing Huang, Ling-shan Gou & Rui-qin Yao. (2021) The Potential Immunomodulatory Properties of Levornidazole Contribute to Improvement in Experimental Ulcerative Colitis. Current Medical Science 41:4, pages 746-756.
Crossref
Lijun Shang, Hongbin Liu, Haitao Yu, Meixia Chen, Tianren Yang, Xiangfang Zeng & Shiyan Qiao. (2021) Core Altered Microorganisms in Colitis Mouse Model: A Comprehensive Time-Point and Fecal Microbiota Transplantation Analysis. Antibiotics 10:6, pages 643.
Crossref
Yuriko Nishikawa, Nobuhiro Sato, Shintaro Tsukinaga, Kan Uchiyama, Shigeo Koido, Dai Ishikawa & Toshifumi Ohkusa. (2021) Long-term outcomes of antibiotic combination therapy for ulcerative colitis. Therapeutic Advances in Chronic Disease 12, pages 204062232110287.
Crossref
Craig Haifer, Rupert W Leong & Sudarshan Paramsothy. (2020) The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease. Current Opinion in Pharmacology 55, pages 8-16.
Crossref
Dan Turner, Jason Bishai, Leah Reshef, Guila Abitbol, Gili Focht, Dana Marcus, Oren Ledder, Raffi Lev-Tzion, Esther Orlanski-Meyer, Baruch Yerushalmi, Marina Aloi, Anne M Griffiths, Lindsey Albenberg, Kaija-Leena Kolho, Amit Assa, Shlomi Cohen, Uri Gophna, Hera Vlamakis, Eberhard Lurz & Arie Levine. (2020) Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial. Inflammatory Bowel Diseases 26:11, pages 1733-1742.
Crossref
Akihiko Oka & R. Balfour Sartor. (2020) Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases. Digestive Diseases and Sciences 65:3, pages 757-788.
Crossref
Bincy Abraham & Eamonn M M Quigley. (2020) Antibiotics and probiotics in inflammatory bowel disease: when to use them?. Frontline Gastroenterology 11:1, pages 62-69.
Crossref
Federica Ungaro, Luca Massimino, Silvia D’Alessio & Silvio Danese. (2019) The gut virome in inflammatory bowel disease pathogenesis: From metagenomics to novel therapeutic approaches. United European Gastroenterology Journal 7:8, pages 999-1007.
Crossref
Madoka Ichikawa-Seki, Daisuke Motooka, Aiko Kinami, Fumi Murakoshi, Yoko Takahashi, Junya Aita, Kei Hayashi, Atsushi Tashibu, Shota Nakamura, Tetsuya Iida, Toshihiro Horii & Yoshifumi Nishikawa. (2019) Specific increase of Fusobacterium in the faecal microbiota of neonatal calves infected with Cryptosporidium parvum. Scientific Reports 9:1.
Crossref
Jessica Breton, Arthur Kastl, Natalie Hoffmann, Rachel Rogers, Andrew B Grossman, Petar Mamula, Judith R Kelsen, Robert N Baldassano & Lindsey Albenberg. (2019) Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases 25:9, pages 1586-1593.
Crossref
Dan Turner, Frank M. Ruemmele, Esther Orlanski‐Meyer, Anne M. Griffiths, Javier Martin de Carpi, Jiri Bronsky, Gabor Veres, Marina Aloi, Caterina Strisciuglio, Christian P. Braegger, Amit Assa, Claudio Romano, Séamus Hussey, Michael Stanton, Mikko Pakarinen, Lissy de Ridder, Konstantinos H. Katsanos, Nick Croft, Víctor Manuel Navas‐López, David C. Wilson, Sally Lawrence & Richard K. Russell. (2018) Management of Paediatric Ulcerative Colitis, Part 2. Journal of Pediatric Gastroenterology and Nutrition 67:2, pages 292-310.
Crossref
Oren Ledder & Dan Turner. (2018) Antibiotics in IBD: Still a Role in the Biological Era?. Inflammatory Bowel Diseases 24:8, pages 1676-1688.
Crossref
Toshifumi Osaka, Eri Moriyama, Shunichi Arai, Yasuhiro Date, Junji Yagi, Jun Kikuchi & Satoshi Tsuneda. (2017) Meta-Analysis of Fecal Microbiota and Metabolites in Experimental Colitic Mice during the Inflammatory and Healing Phases. Nutrients 9:12, pages 1329.
Crossref
Mahmoud H Mosli, Claire E Parker, Sigrid A Nelson, Kenneth A Baker, John K MacDonald, GY Zou, Brian G Feagan, Reena Khanna, Barrett G Levesque & Vipul Jairath. (2017) Histologic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database of Systematic Reviews 2017:7.
Crossref
Lindsey Albenberg, Howard Kader & Adam Paul. 2017. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 325 331 .
Shailja C. Shah, Jean-Frederic Colombel, Bruce E. Sands & Neeraj Narula. (2016) Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 14:9, pages 1245-1255.e8.
Crossref
Toshifumi Ohkusa & Shigeo Koido. (2015) Intestinal microbiota and ulcerative colitis. Journal of Infection and Chemotherapy 21:11, pages 761-768.
Crossref
Giovanni Cammarota, Gianluca Ianiro, Rossella Cianci, Stefano Bibbò, Antonio Gasbarrini & Diego Currò. (2015) The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy. Pharmacology & Therapeutics 149, pages 191-212.
Crossref
Takahiro Shimizu, Hironao Ohtake, Takuto Fujii, Yoshiaki Tabuchi & Hideki Sakai. (2014) Volume-sensitive outwardly rectifying Cl− channels contribute to butyrate-triggered apoptosis of murine colonic epithelial MCE301 cells. The Journal of Physiological Sciences 65:2, pages 151-157.
Crossref
Mohamed Bejaoui, Harry Sokol & Philippe Marteau. (2015) Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons. Digestive Diseases 33:Suppl. 1, pages 105-112.
Crossref
Emma Allen-Vercoe. (2014) Fusobacterium varium in Ulcerative Colitis: Is It Population-Based?. Digestive Diseases and Sciences 60:1, pages 7-8.
Crossref
Katsuyoshi Matsuoka & Takanori Kanai. (2014) The gut microbiota and inflammatory bowel disease. Seminars in Immunopathology 37:1, pages 47-55.
Crossref
Dan Turner, Arie Levine, Kaija-Leena Kolho, Ron Shaoul & Oren Ledder. (2014) Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: A preliminary report. Journal of Crohn's and Colitis 8:11, pages 1464-1470.
Crossref
K. Kato & T. Ohkusa. (2014) Commentary: adjunct antibiotic combination therapy for ulcerative colitis – is it time to investigate F usobacterium varium ? Authors' reply . Alimentary Pharmacology & Therapeutics 39:11, pages 1333-1334.
Crossref
K. Kato, T. Ohkusa, S. Terao, T. Chiba, K. Murakami, A. Yanaka, T. Uehara, Y. Ishii, M. Soma & H. Tajiri. (2014) Adjunct antibiotic combination therapy for steroid‐refractory or ‐dependent ulcerative colitis: an open‐label multicentre study. Alimentary Pharmacology & Therapeutics 39:9, pages 949-956.
Crossref
Mahmoud H. Mosli, Brian G. Feagan, William J. Sandborn, Geert DʼHaens, Cynthia Behling, Keith Kaplan, David K. Driman, Lisa M. Shackelton, Kenneth A. Baker, John K. MacDonald, Margaret K. Vandervoort, Karel Geboes & Barrett G. Levesque. (2014) Histologic Evaluation of Ulcerative Colitis. Inflammatory Bowel Diseases 20:3, pages 564-575.
Crossref
. 2014. Intestinal Microbiota in Health and Disease. Intestinal Microbiota in Health and Disease 229 237 .
Wei-Xu Chen. (2014) Enteric microbiota leads to new therapeutic strategies for ulcerative colitis. World Journal of Gastroenterology 20:42, pages 15657.
Crossref
Harry Sokol. (2014) Probiotics and Antibiotics in IBD. Digestive Diseases 32:Suppl. 1, pages 10-17.
Crossref
Dan Turner. (2014) Relapsing and Refractory Ulcerative Colitis in Children. Digestive Diseases 32:4, pages 419-426.
Crossref
Frank I. Scott & Faten N. Aberra. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis 209 220 .
Li-Xuan Sang, Bing Chang, Cong Dai, Nan Gao, Wei-Xin Liu & Min Jiang. (2013) Heat-killed VSL#3 Ameliorates Dextran Sulfate Sodium (DSS)-Induced Acute Experimental Colitis in Rats. International Journal of Molecular Sciences 15:1, pages 15-28.
Crossref
Jun Fang, Takahiro Seki, Tetsuya Tsukamoto, Haibo Qin, Hongzhuan Yin, Long Liao, Hideaki Nakamura & Hiroshi Maeda. (2013) Protection from inflammatory bowel disease and colitis-associated carcinogenesis with 4-vinyl-2,6-dimethoxyphenol (canolol) involves suppression of oxidative stress and inflammatory cytokines. Carcinogenesis 34:12, pages 2833-2841.
Crossref
Toyokazu Yukawa, Toshifumi Ohkusa, Tomoyoshi Shibuya, Shintaro Tsukinaga, Jimi Mitobe, Kazuki Takakura, Akitaka Takahara, Shunichi Odahara, Hiroshi Matsudaira, Keisuke Nagatsuma, Takuya Kitahara, Mikio Kajihara, Kan Uchiyama, Hiroshi Arakawa, Shigeo Koido & Hisao Tajiri. (2013) Nested Culture Method Improves Detection of Fusobacterium from Stool in Patients with Ulcerative Colitis. Japanese Journal of Infectious Diseases 66:2, pages 109-114.
Crossref
Howard Kader, Douglas Jacobstein & Adam Paul. 2013. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 289 294 .
SHENG-LAN WANG, ZHI-RONG WANG & CHANG-QING YANG. (2012) Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease. Experimental and Therapeutic Medicine 4:6, pages 1051-1056.
Crossref
Franco Scaldaferri, Marco Pizzoferrato, Silvia Pecere, Fabrizio Forte & Antonio Gasbarrini. (2012) Bacterial Flora as a Cause or Treatment of Chronic Diarrhea. Gastroenterology Clinics of North America 41:3, pages 581-602.
Crossref
R Balfour Sartor & Sarkis K Mazmanian. (2012) Intestinal Microbes in Inflammatory Bowel Diseases. The American Journal of Gastroenterology Supplements 1:1, pages 15-21.
Crossref
Isao Okayasu. (2012) Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ‐specific chronic inflammation‐carcinoma sequence. Pathology International 62:6, pages 368-380.
Crossref
Maiko Sasaki & Jan-Michael A. Klapproth. (2012) The Role of Bacteria in the Pathogenesis of Ulcerative Colitis. Journal of Signal Transduction 2012, pages 1-6.
Crossref
Khurram J Khan, Thomas A Ullman, Alexander C Ford, Maria T Abreu, A Abadir, John K Marshall, Nicholas J Talley & Paul Moayyedi. (2011) Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology 106:4, pages 661-673.
Crossref
Nicholas J Talley, Maria T Abreu, Jean-Paul Achkar, Charles N Bernstein, Marla C Dubinsky, Stephen B Hanauer, Sunanda V Kane, William J Sandborn, Thomas A Ullman & Paul Moayyedi. (2011) An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease. American Journal of Gastroenterology 106, pages S2-S25.
Crossref
Tsutomu Yoshida, Tsukasa Sekine, Ken-ichi Aisaki, Tetuo Mikami, Jun Kanno & Isao Okayasu. (2010) CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid. Journal of Gastroenterology 46:3, pages 339-349.
Crossref
Richard N. Fedorak, Levinus A. Dieleman & Karen L. Madsen. 2011. Inflammatory Bowel Disease. Inflammatory Bowel Disease 123 150 .
Toshifumi Ohkusa, Kimitoshi Kato, Shuichi Terao, Toshimi Chiba, Katsuhiro Mabe, Kazunari Murakami, Yuji Mizokami, Toshiro Sugiyama, Akinori Yanaka, Yoshiaki Takeuchi, Shigeru Yamato, Tetsuji Yokoyama, Isao Okayasu, Sumio Watanabe, Hisao Tajiri & Nobuhiro Sato. (2010) Newly Developed Antibiotic Combination Therapy for Ulcerative Colitis: A Double-Blind Placebo-Controlled Multicenter Trial. American Journal of Gastroenterology 105:8, pages 1820-1829.
Crossref
Toshiki Uehara, Kimitoshi Kato, Toshifumi Ohkusa, Masahiko Sugitani, Yukimoto Ishii, Norimichi Nemoto & Mitsuhiko Moriyama. (2010) Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid‐dependent cases. Journal of Gastroenterology and Hepatology 25:s1.
Crossref
Hideki Masuda. (2010) . Journal of Nihon University Medical Association 69:2, pages 99-105.
Crossref
Toshifumi Ohkusa, Tsutomu Yoshida, Nobuhiro Sato, Sumio Watanabe, Hisao Tajiri & Isao Okayasu. (2009) Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis. Journal of Medical Microbiology 58:5, pages 535-545.
Crossref
S.P.L. Travis, E.F. Stange, M. Lémann, T. Øresland, W.A. Bemelman, Y. Chowers, J.F. Colombel, G. D'Haens, S. Ghosh, P. Marteau, W. Kruis, N.J.McC. Mortensen, F. Penninckx & M. Gassull. (2008) European evidence-based Consensus on the management of ulcerative colitis: Current management. Journal of Crohn's and Colitis 2:1, pages 24-62.
Crossref
R. Balfour Sartor. (2008) Microbial Influences in Inflammatory Bowel Diseases. Gastroenterology 134:2, pages 577-594.
Crossref
Douglas Jacobstein & Howard Kader. 2008. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 329 336 .
R. Balfour Sartor & Marcus Muehlbauer. (2007) Microbial host interactions in IBD: Implications for pathogenesis and therapy. Current Gastroenterology Reports 9:6, pages 497-507.
Crossref
Prabhakar P. Swaroop. (2007) Inflammatory Bowel Diseases in the Elderly. Clinics in Geriatric Medicine 23:4, pages 809-821.
Crossref
Roja Rahimi, Shekoufeh Nikfar, Ali Rezaie & Mohammad Abdollahi. (2007) A Meta-Analysis of Antibiotic Therapy for Active Ulcerative Colitis. Digestive Diseases and Sciences 52:11, pages 2920-2925.
Crossref
Sreedhar Subramanian, Barry James Campbell & Jonathan Michael Rhodes. (2006) Bacteria in the pathogenesis of inflammatory bowel disease. Current Opinion in Infectious Diseases 19:5, pages 475-484.
Crossref
Kenneth W. Simpson, Belgin Dogan, Mark Rishniw, Richard E. Goldstein, Suzanne Klaessig, Patrick L. McDonough, Alex J. German, Robin M. Yates, David G. Russell, Susan E. Johnson, Douglas E. Berg, Josee Harel, Guillaume Bruant, Sean P. McDonough & Ynte H. Schukken. (2006) Adherent and Invasive Escherichia coli Is Associated with Granulomatous Colitis in Boxer Dogs . Infection and Immunity 74:8, pages 4778-4792.
Crossref
Molly Perencevich & Robert Burakoff. (2006) Use of antibiotics in the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases 12:7, pages 651-664.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.